Teprotumumab increases risk of audiological events

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2024年 / 2039卷 / 1期
关键词：
D O I：
10.1007/s40278-024-72448-0
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：11 / 11
相关论文
共 50 条
  • [31] Hospitalization in the Year Prior to Oncologic Resection Increases Risk of Adverse Events
    Sharoky, C.
    Collier, K.
    Wirtalla, C.
    Sinnamon, A.
    Neuwirth, M.
    Roses, R.
    Fraker, D. L.
    Karakousis, G.
    Kelz, R. R.
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 : S162 - S162
  • [32] Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting
    A. Germing
    S. von Dryander
    Abderrahman Machraoui
    Waldemar Bojara
    Thomas Lawo
    Peter Grewe
    Jürgen Barmeyer
    Bernd Lemke
    Heart and Vessels, 2000, 15 : 263 - 267
  • [33] ASPIRIN FOR PRIMARY PREVENTION REDUCES CARDIOVASCULAR EVENTS, INCREASES BLEEDING RISK
    Rosenberg, Karen
    AMERICAN JOURNAL OF NURSING, 2019, 119 (05) : 66 - 66
  • [34] Reproductive endocrinology: Low testosterone increases risk of cardiovascular events in women
    Greenhill C.
    Nature Reviews Endocrinology, 2010, 6 (11) : 597 - 597
  • [35] Hyperfibrinogenemia increases the risk of cardiac events after coronary artery stenting
    Germing, A
    von Dryander, S
    Machraoui, A
    Bojara, W
    Lawo, T
    Grewe, P
    Barmeyer, J
    Lemke, B
    HEART AND VESSELS, 2000, 15 (06) : 263 - 267
  • [36] Prevalence, risk factors, and audiological characteristics of auditory neuropathy
    Almishaal, Ali A.
    Saleh, Shaza
    Alferaih, Hala
    Alhelo, Osamah
    INTERNATIONAL JOURNAL OF AUDIOLOGY, 2022, 61 (12) : 1018 - 1026
  • [37] Short-term use of rofecoxib increases the risk for adverse cardiovascular events
    Nature Clinical Practice Oncology, 2007, 4 : 621 - 621
  • [38] Young age at diabetes diagnosis increases the risk of related serious adverse events
    Ikazoboh, E. C.
    Hutchison, A.
    Jones, D. Russell
    de Vries, C. S.
    DIABETIC MEDICINE, 2007, 24 : 79 - 79
  • [39] Systemic administration of bevacizumab increases the risk of cardiovascular events in patients with metastatic cancer
    Stefanadis, Christodoulos
    Synetos, Andreas
    Tousoulis, Dimitris
    Tsiamis, Eleftherios
    Michelongona, Archontoula
    Zagouri, Flora
    Bamias, Aristotle
    Dimopoulos, Meletios Athanasios
    Kyvelou, Stella
    Kapelakis, Ioannis
    Toutouzas, Konstantinos
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2012, 154 (03) : 341 - 344
  • [40] Review: Varenicline increases risk for serious adverse cardiovascular events in tobacco users
    Brophy, James M.
    ANNALS OF INTERNAL MEDICINE, 2011, 155 (08)
12345